A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan
Clinical trial NCT05359081 · TERMINATED
Trial details
- NCT number
- NCT05359081
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2024-03-21
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.